Neurokinin-1 Receptor Antagonist-Based Triple Regimens in Preventing Chemotherapy-Induced Nausea and Vomiting: A Network Meta-Analysis

Yaxiong Zhang; Yunpeng Yang; Zhonghan Zhang; Wenfeng Fang; Shiyang Kang; Youli Luo; Jin Sheng; Jianhua Zhan; Shaodong Hong; Yan Huang; Ningning Zhou; Hongyun Zhao; Li Zhang

doi:10.1093/jnci/djw217

Neurokinin-1 Receptor Antagonist-Based Triple Regimens in Preventing Chemotherapy-Induced Nausea and Vomiting: A Network Meta-Analysis

JNCI Journal of the National Cancer Institute ◽

10.1093/jnci/djw217 ◽

2016 ◽

Vol 109 (2) ◽

pp. djw217 ◽

Cited By ~ 13

Author(s):

Yaxiong Zhang ◽

Yunpeng Yang ◽

Zhonghan Zhang ◽

Wenfeng Fang ◽

Shiyang Kang ◽

...

Keyword(s):

Receptor Antagonist ◽

Meta Analysis ◽

Nausea And Vomiting ◽

Neurokinin 1 Receptor ◽

Neurokinin 1

Download Full-text

Efficacy of the combination neurokinin-1 receptor antagonist, palonosetron, and dexamethasone compared to others for the prophylaxis of chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis of randomized controlled trials

Annals of Palliative Medicine ◽

10.21037/apm.2018.03.09 ◽

2018 ◽

Vol 7 (2) ◽

pp. 221-233 ◽

Cited By ~ 4

Author(s):

Ronald Chow ◽

May Tsao ◽

Leonard Chiu ◽

Marko Popovic ◽

Milica Milakovic ◽

...

Keyword(s):

Systematic Review ◽

Randomized Controlled Trials ◽

Receptor Antagonist ◽

Meta Analysis ◽

Nausea And Vomiting ◽

Controlled Trials ◽

Neurokinin 1 Receptor ◽

Randomized Controlled ◽

Neurokinin 1

Download Full-text

Olanzapine‐Based Triple Regimens Versus Neurokinin‐1 Receptor Antagonist‐Based Triple Regimens in Preventing Chemotherapy‐Induced Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy: A Network Meta‐Analysis

The Oncologist ◽

10.1634/theoncologist.2017-0378 ◽

2018 ◽

Vol 23 (5) ◽

pp. 603-616 ◽

Cited By ~ 4

Author(s):

Zhonghan Zhang ◽

Yaxiong Zhang ◽

Gang Chen ◽

Shaodong Hong ◽

Yunpeng Yang ◽

...

Keyword(s):

Receptor Antagonist ◽

Meta Analysis ◽

Emetogenic Chemotherapy ◽

Nausea And Vomiting ◽

Highly Emetogenic Chemotherapy ◽

Neurokinin 1 Receptor ◽

Neurokinin 1

Download Full-text

Efficacy of thalidomide, neurokinin-1 receptor antagonist, and olanzapine in combination with palonosetron plus dexamethasone in preventing chemotherapy-induced nausea and vomiting (CINV) induced by highly emetogenic chemotherapy (HEC): Bayesian network meta-analysis.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e14514 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e14514-e14514

Author(s):

Abdullah Alhifany ◽

Ali McBride ◽

Abdulaali Almutairi ◽

Hani M. Babiker ◽

Karen MacDonald ◽

...

Keyword(s):

Bayesian Network ◽

Receptor Antagonist ◽

Meta Analysis ◽

Emetogenic Chemotherapy ◽

Nausea And Vomiting ◽

Highly Emetogenic Chemotherapy ◽

Neurokinin 1 Receptor ◽

Neurokinin 1

Download Full-text

Fosaprepitant (MK-0517): a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting

Expert Opinion on Investigational Drugs ◽

10.1517/13543784.16.12.1977 ◽

2007 ◽

Vol 16 (12) ◽

pp. 1977-1985 ◽

Cited By ~ 28

Author(s):

Rudolph M Navari

Keyword(s):

Receptor Antagonist ◽

Nausea And Vomiting ◽

Neurokinin 1 Receptor ◽

Neurokinin 1

Download Full-text

Neurokinin-1 receptor antagonists for postoperative nausea and vomiting: a systematic review and meta-analysis

Brazilian Journal of Anesthesiology (English Edition) ◽

10.1016/j.bjane.2020.06.015 ◽

2020 ◽

Vol 70 (5) ◽

pp. 508-519

Author(s):

Chiaki Murakami ◽

Nami Kakuta ◽

Shiho Satomi ◽

Ryuji Nakamura ◽

Hirotsugu Miyoshi ◽

...

Keyword(s):

Systematic Review ◽

Postoperative Nausea ◽

Meta Analysis ◽

Postoperative Nausea And Vomiting ◽

Nausea And Vomiting ◽

Receptor Antagonists ◽

Neurokinin 1 Receptor ◽

Neurokinin 1

Download Full-text

Phase II Study to Evaluate the Safety and Efficacy of the Oral Neurokinin-1 Receptor Antagonist Casopitant (GW679769) Administered With Ondansetron for the Prevention of Postoperative and Postdischarge Nausea and Vomiting in High-Risk Patients

Survey of Anesthesiology ◽

10.1097/sa.0b013e31820eca68 ◽

2011 ◽

Vol 55 (2) ◽

pp. 94-97

Author(s):

&NA;

Keyword(s):

High Risk ◽

Receptor Antagonist ◽

Phase Ii ◽

Phase Ii Study ◽

Nausea And Vomiting ◽

Safety And Efficacy ◽

Neurokinin 1 Receptor ◽

High Risk Patients ◽

Risk Patients ◽

Neurokinin 1

Download Full-text

Efficacy of the oral neurokinin-1 receptor antagonist aprepitant administered with ondansetron for the prevention of postoperative nausea and vomiting

Korean Journal of Anesthesiology ◽

10.4097/kjae.2013.64.3.212 ◽

2013 ◽

Vol 64 (3) ◽

pp. 212 ◽

Cited By ~ 12

Author(s):

Chae Seong Lim ◽

Young-Kwon Ko ◽

Yoon-Hee Kim ◽

Sang-Il Park ◽

Jae-Kook Kim ◽

...

Keyword(s):

Receptor Antagonist ◽

Postoperative Nausea ◽

Postoperative Nausea And Vomiting ◽

Nausea And Vomiting ◽

Neurokinin 1 Receptor ◽

Neurokinin 1

Download Full-text

Efficacy of olanzapine, neurokinin-1 receptor antagonists, and thalidomide in combination with palonosetron plus dexamethasone in preventing highly emetogenic chemotherapy-induced nausea and vomiting: a Bayesian network meta-analysis

Supportive Care in Cancer ◽

10.1007/s00520-019-05210-4 ◽

2019 ◽

Vol 28 (3) ◽

pp. 1031-1039 ◽

Cited By ~ 1

Author(s):

Abdullah A. Alhifany ◽

Ali McBride ◽

Abdulaali R. Almutairi ◽

Ejaz Cheema ◽

Alaa Shahbar ◽

...

Keyword(s):

Bayesian Network ◽

Meta Analysis ◽

Emetogenic Chemotherapy ◽

Nausea And Vomiting ◽

Receptor Antagonists ◽

Highly Emetogenic Chemotherapy ◽

Neurokinin 1 Receptor ◽

Neurokinin 1

Download Full-text

Efficacy of oral casopitant mesylate, a novel neurokinin-1 receptor antagonist, with intravenous ondansetron HCl in the prevention of postoperative nausea and vomiting (PONV) in high-risk patients

European Journal of Anaesthesiology ◽

10.1097/00003643-200606001-00573 ◽

2006 ◽

Vol 23 (Supplement 37) ◽

pp. 159-160 ◽

Cited By ~ 1

Author(s):

N. Singla ◽

F. Chung ◽

S. Singla ◽

A. Grenier ◽

D. Kutsogiannis ◽

...

Keyword(s):

High Risk ◽

Receptor Antagonist ◽

Postoperative Nausea ◽

Postoperative Nausea And Vomiting ◽

Nausea And Vomiting ◽

Neurokinin 1 Receptor ◽

High Risk Patients ◽

Risk Patients ◽

Neurokinin 1

Download Full-text

Efficacy of neurokinin-1 receptor antagonists in the prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in patients receiving carboplatin-based chemotherapy: a systematic review and meta-analysis

Annals of Oncology ◽

10.1093/annonc/mdx435.005 ◽

2017 ◽

Vol 28 ◽

pp. vi90 ◽

Cited By ~ 1

Author(s):

M. Di Maio ◽

C. Baratelli ◽

P. Bironzo ◽

F. Vignani ◽

E. Bria ◽

...

Keyword(s):

Systematic Review ◽

Meta Analysis ◽

Nausea And Vomiting ◽

Receptor Antagonists ◽

Neurokinin 1 Receptor ◽

Neurokinin 1

Download Full-text